If you go back to past 2a trials for the HCV drugs you will see big gains from 2a results .
The new timetable .
http://www.informedhorizons.com/hepdart2011/pdf/Program_HEPDART2011_web.pdf
Our presentation is Tuesday 6th December 2011 . 10:10 am Hawaii time ( 5.40am CST next Wednesday ).
" Antiviral activity and tolerability of BIT225 plus pegylated interferon alpha 2a or 2b and weight-based ribavirin for 28 days in HCV treatment-naïve monoinfected patients .
( by Tawesak Tanwandee, Siriraj Hospital/Mahidol University, Thailand ) .
Our Professor R. Murphy is the Chairperson .
location/location/location, page-28
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
